Skip to main content

Advertisement

Table 2 32 TCGA cancer types used in this study

From: Correlate tumor mutation burden with immune signatures in human cancers

Cancer Full name # cancer samples c # normal samples # higher-TMB samples # lower-TMB samples
ACC adrenocortical carcinoma 79 0 16 20
BLCA bladder urothelial carcinoma 408 19 99 97
BRCA breast invasive carcinoma 1100 112 241 245
CESC cervical squamous-cell carcinoma and endocervical adeno-carcinoma 306 3 50 46
CHOL cholangiocarcinoma 36 9 9 9
COAD colon adenocarcinoma 287 41 53 49
DLBC lymphoid neoplasm diffuse large B-cell lymphoma 48 0 12 12
ESCA esophageal carcinoma 185 11 45 46
GBM glioblastoma multiforme 166 5 41 30
HNSC head and neck squamous cell carcinoma 522 44 127 123
KICH kidney chromophobe 66 25 17 17
KIRC kidney renal clear cell carcinoma 534 72 120 110
KIRP kidney renal papillary cell carcinoma 291 32 70 68
LAML acute myeloid leukemia 173 0 24 24
LGG brain lower-grade glioma 530 0 69 66
LIHC liver hepatocellular carcinoma 373 50 90 87
LUAD lung adenocarcinoma 517 59 120 127
LUSC lung squamous cell carcinoma 501 51 45 45
OV ovarian serous cystadeno-carcinoma 307 0 29 22
PAAD pancreatic adeno-carcinoma 179 4 46 38
PCPG pheochromocytoma and paraganglioma 184 3 45 41
PRAD prostate adenocarcinoma 498 52 119 113
READ rectum adenocarcinoma 95 10 19 20
SARC sarcoma 263 2 63 64
SKCM skincutaneous melanoma 472 1 117 118
STAD stomach adenocarcinoma 415 35 90 85
TGCT testicular germ-cell tumors 156 0 39 35
THCA thyroid carcinoma 509 59 122 108
THYM thymoma 120 2 29 29
UCEC uterine corpus endometrial carcinoma 370 11 59 60
UCS uterine carcino-sarcoma 57 0 14 13
UVM uveal melanoma 80 0 20 19
  1. cThe numbers of cancer samples with both somatic mutations and gene expression profiles data